Social Media Sidebar

Announcement

Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

When seen through the lens of technology, few resources are truly scarce; they’re mainly inaccessible. 

 

Peter Diamandis

Radical new approach to schizophrenia treatment begins trial

RATE THIS! +29
Posted in Science on 5th Nov, 2017 04:00 AM by Alex Muller

Scientists have begun testing a radically new approach to treating schizophrenia based on emerging evidence that it could be a disease of the immune system. The first patient, a 33-year old man who developed schizophrenia, was treated at King’s College Hospital in London.

 
During the next two years, 30 patients will receive monthly infusions of an antibody drug currently used to treat multiple sclerosis (MS), which the team hopes will target the root causes of schizophrenia in a far more fundamental way than current therapies.
 
The trial builds on more than a decade’s work by Oliver Howes, a professor of molecular psychiatry at the MRC London Institute of Medical Sciences and a consultant psychiatrist at the Maudsley Hospital in south London. Howes’s team is one of several worldwide to have uncovered evidence that abnormalities in immune activity in the brain may lie at the heart of the illness – for some patients, at least.
 
“In the past, we’ve always thought of the mind and the body being separate, but it’s just not like that,” said Howes. “The mind and body interact constantly and the immune system is no different. It’s about changing the way we think about mental illnesses.”
 
Recent work by Howes and colleagues found that in the earliest stages of schizophrenia, people experience a surge in the number and activity of immune cells in the brain. As well as fighting infection, these cells, called microglia, have a “gardening” role, pruning unwanted connections between neurons. But in schizophrenia patients, the pruning appears to become more aggressive, leading to vital connections being lost.
 
“We studied people in that [initial] phase of the illness and saw microglial changes,” said Howes. “It shows that it’s something [happening] very early on and seems to be driving the illness.”
 
The most extensive pruning appears to occur in the frontal cortex, the brain’s master control centre, and also the auditory regions, which could explain why patients often hear voices. The frontal cortex indirectly controls the brain’s levels of dopamine – a surge in this brain chemical is thought to explain the delusions and paranoia experienced by those with schizophrenia.
 
Nearly all existing medications work by blocking dopamine, which can bring psychotic symptoms under control, but fail to protect the brain’s basic architecture from damage.
 
“The current drugs are based on 1950s technology; they all still work in exactly the same way,” said Howes. “They are only able to target the delusion side of things. It’s like getting a sledgehammer and squashing it down.”
 
There is a growing appreciation that other, perhaps less well-known, symptoms associated with schizophrenia – memory and cognitive problems, and lack of motivation – can have an equally profound impact on patients, and existing drugs do little to help this side of the disease. “It’s typically [these other] symptoms that are the most disabling,” said Toby Pillinger, a psychiatrist and King’s College London researcher involved in the study.
 
The latest trial, a collaboration between MRC scientists and King’s College London, involves treating patients with a monoclonal antibody drug, called Natalizumab, that is already licensed for MS. In MS, the brain’s immune cells go awry by attacking a different aspect of the brain’s wiring. And although the diseases manifest in very different ways, apparent parallels in the underlying biology raise the possibility that the MS drug might help schizophrenia patients.
 
The drug works by targeting microglia and restricting their movement around the brain, which scientists hope could prevent the over-pruning of vital connections. In doing so, it could potentially address the disease’s full spectrum of symptoms.

Tags: brainhealthmedicinedrugresearch

Read original article » Back to category

Comments

Author: Guest
Posted: 2017-11-06
+1
The role of microglia is complex and important for many aspects of brain function and not surprisingly these immune cells are also implicated in various disorders
1 Replies
Author: Guest
Posted: 2017-11-06
+2
Indeed, it seems that the link between the immune system and brain disorders in prevalent mental health issues is the key to bring about new treatments for schizophrenia, Alzheimer's or MS Reply
Reply


 

Recent headlines

  • Posted in Science on 2017-11-20 00:42:21
    Small steps forward as UN climate talks end in Bonn..read more
    Posted in Hardware on 2017-11-20 00:37:56
    US gov should support SpaceX and develop moon bases..read more
    Posted in Business on 2017-11-18 21:15:58
    Companies are realising that renewable energy is good for.....read more
    Posted in Hardware on 2017-11-18 21:07:25
    California may reach 50% renewable power goal by 2020; 10.....read more
    Posted in Hardware on 2017-11-17 18:02:34
    Tesla unveils a truck and a roadster..read more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in about.....read more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for commercial.....read more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 Downloads..read more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into new.....read more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs,.....read more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for commercial.....read more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short Sighted..read more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, but.....read more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in about.....read more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target mitochondria..read more

Recent Blog Posts

  • Posted by AlexMuller
    Martian landscapes formed from sand 'levitating' on a little.....read more
    Posted by AlexMuller
    Scientists detect comets outside our solar system..read more
    Posted by AlexMuller
    Advanced artificial limbs mapped in the brain..read more
    Posted by AlexMuller
    Bacteria have a sense of touch..read more
    Posted by AlexMuller
    Recurrent brain cancer: New hope with phase 1 clinical trial.....read more

Login to your Account

Login to your PlanetTech Account here

Username:
Password:
Remember me
or

Create a New Account

You just need username and password

The following errors occured:
Username:
Email:
Password:
Verify password:
Remember me